Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 EPS of $0.05, $0.03 better than the analyst estimate of $0.02. Revenue for the quarter came in at $76.68 million versus the consensus estimate of $72.52 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.